Long-term LDL-c lowering in heterozygous familial hypercholesterolemia normalizes carotid intima-media thickness

Atherosclerosis

Volumn 212, Issue 2, 2010, Pages 571-574

  Sivapalaratnam, S ^a   van Loendersloot, L L ^a   Hutten, B A ^a   Kastelein, J J P ^a   Trip, M D ^a   de Groot, E ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Atherosclerosis; CIMT; FH; Long term treatment

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE DISTRIBUTION; ARTERIAL WALL THICKNESS; ARTICLE; CAROTID ARTERY; CAROTID ATHEROSCLEROSIS; CAROTID INTIMA MEDIA THICKNESS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DISEASE MARKER; DRUG EFFICACY; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HETEROZYGOSITY; HUMAN; LONG TERM CARE; MALE; PRIORITY JOURNAL; SEX RATIO; SPOUSE; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; ANTICHOLESTEREMIC AGENTS; CAROTID ARTERIES; CASE-CONTROL STUDIES; CHOLESTEROL, LDL; FAMILY HEALTH; FEMALE; HETEROZYGOTE; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; SPOUSES; TUNICA INTIMA; TUNICA MEDIA;

EID: 77957706276     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.06.040     Document Type: Article

References (16)

1. Goldstein J.L., Hobbs H.H., Brown M.S. Familial hypercholesterolemia. The metabolic and molecular basis of inherited disease 2007, McGrawHill, New York. A.L. Baudet, B. Vogelstein, K. Kinzler, A. Atonarakis, A. Ballabio (Eds.).
2. Huijgen R., Vissers M.N., Defesche J.C., Lansberg P.J., Kastelein J.J., Hutten B.A. Familial hypercholesterolemia: current treatment and advances in management. Expert Rev Cardiovasc Ther 2008, (6):567-581.
3. van Aalst-Cohen E.S., Jansen A.C., Tanck M.W., et al. Diagnosing familial hypercholesterolaemia: the relevance of genetic testing. Eur Heart J 2006, (27):2240-2246.
4. Stone N.J., Levy R.I., Fredrickson D.S., Verter J. Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia. Circulation 1974, (49):476-488.
5. Slack J. Risks of ischaemic heart-disease in familial hyperlipoproteinaemic states. Lancet 1969, (2):1380-1382.
6. Havel R.J., Hunninghake D.B., Illingworth D.R., et al. Lovastatin (mevinolin) in the treatment of heterozygous familial hypercholesterolemia. A multicenter study. Ann Intern Med 1987, (107):609-615.
7. Smilde T.J., van W.S., Wollersheim H., Trip M.D., Kastelein J.J., Stalenhoef A.F. Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial. Lancet 2001, (357):577-581.
8. de Sauvage Nolting P.R., Buirma R.J., Hutten B.A., Kastelein J.J. Two-year efficacy and safety of simvastatin 80mg in familial hypercholesterolemia (the Examination of Probands and Relatives in Statin Studies With Familial Hypercholesterolemia [ExPRESS FH]). Am J Cardiol 2002, (90):181-184.
9. Neil A., Cooper J., Betteridge J., et al. Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study. Eur Heart J 2008, (29):2625-2633.
10. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, (18):499-502.
11. Groot de E., Hovingh G.K., Wiegman A., et al. Measurement of arterial wall thickness as a surrogate marker for atherosclerosis. Circulation 2004, (109):III33-III38.
12. Groot de E., Zwinderman A.H., van der Steen A.F., et al. Variance components analysis of carotid and femoral intima-media thickness measurements. REGRESS Study Group, Interuniversity Cardiology Institute of The Netherlands, Utrecht, The Netherlands. Regression Growth Evaluation Statin Study. Ultrasound Med Biol 1998, (24):825-832.
13. Lorenz M.W., Markus H.S., Bots M.L., Rosvall M., Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 2007, (115):459-467.
14. Versmissen J., Oosterveer D.M., Yazdanpanah M., et al. Efficacy of statins in familial hypercholesterolaemia: a long term cohort study. BMJ 2008, (337):a2423.
15. Espeland M.A., O'Leary D.H., Terry J.G., et al. Carotid intimal-media thickness as a surrogate for cardiovascular disease events in trials of HMG-CoA reductase inhibitors. Curr Control Trials Cardiovasc Med 2005, (6):3.
16. Kastelein J.J., Akdim F., Stroes E.S., et al. Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med 2008, (358):1431-1443.